Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

By Nishikawa Y.   Inoue N.   Xuan X.   Nagasawa H.   Igarashi I.   Fujisaki K.   Otsuka H.   Mikami T.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1381-1390

Elsevier

Access to resources Recommend Favorite

Rabies vaccination: comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines

By Lodmell D.L.   Ewalt L.C.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2394-2398

Elsevier

Access to resources Recommend Favorite

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies

By Rose R.C.   Lane C.   Wilson S.   Suzich J.A.   Rybicki E.   Williamson A.-L.  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2129-2135

Elsevier

Access to resources Recommend Favorite

A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis

By El Kasmi K.C.   Theisen D.   Brons N.H.C.   Ammerlaan W.   Klingele M.   Truong A.T.   Muller C.P.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2436-2445

Elsevier

Access to resources Recommend Favorite

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

By Arribillaga L.   de Cerio A.L.D.   Sarobe P.   Casares N.   Gorraiz M.   Vales A.   Bruna-Romero O.   Borras-Cuesta F.   Paranhos-Baccala G.   Prieto J.   Ruiz J.   Lasarte J.J.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 202-210

Elsevier

Access to resources Recommend Favorite